DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vfend (Voriconazole) - Serious Reactions - Suspected Cause - Side Effect Reports

 
 



Index of reports > Serious Reactions (239)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vfend (Voriconazole) serious reactions. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 239   Next >>

Possible Vfend side effects in 65 year old female

Reported by a physician from Japan on 2012-08-24

Patient: 65 year old female, weighing 57.0 kg (125.4 pounds)

Reactions: Bronchopulmonary Aspergillosis, Drug Interaction, Anaemia Macrocytic, Hypertriglyceridaemia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient possibly interacting with the suspect drug:
Lipitor
    Dosage: 10 mg, 1x/day
    Administration route: Oral
    Start date: 2011-10-19
    End date: 2012-02-15

Other drugs received by patient: Neoral; Basen; Sulfamethoxazole and Trimethoprim; Prednisolone; Bonalen(alendronate Sodium); Fungizone; Lansoprazole; Candesartan Cilexetil; Metformin HCL



Possible Vfend side effects in 65 year old female

Reported by a physician from Switzerland on 2012-08-24

Patient: 65 year old female, weighing 38.0 kg (83.6 pounds)

Reactions: Hyperkalaemia, Adrenal Insufficiency, Hyponatraemia, Convulsion

Drug(s) suspected as cause:
Aldactone
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-31

Prednisone
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Start date: 2012-07-27

Prednisone
    Dosage: 30 mg, 1x/day
    Administration route: Oral
    Start date: 2012-07-18
    End date: 2012-07-26

Prednisone
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    End date: 2012-07-17

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-07-26

Other drugs received by patient: Prograf; Zithromax; Aspirin; Prograf; Myfortic; Liquaemin INJ



Possible Vfend side effects in 78 year old male

Reported by a pharmacist from Japan on 2012-08-24

Patient: 78 year old male

Reactions: Disorientation, Delirium, Eye Disorder

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 52 year old female

Reported by a consumer/non-health professional from United States on 2012-08-24

Patient: 52 year old female

Reactions: Pneumonia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-24

Patient: male

Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Graft Versus Host Disease in Liver, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haemolysis, Haematotoxicity, Epstein-Barr Virus Infection, Renal Failure, Renal Impairment, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Dosage: 20 g, qd
    End date: 2012-03-06

Bactrim DS
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Dosage: 1.5 g, unk
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Indication: Vitamin Supplementation
    End date: 2012-04-05

Heparin Calcium
    Dosage: 7500 (units unknown), once daily
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Dosage: 150 ug, qd
    Indication: Hypothyroidism

Nicardipine HCL
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 miu, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Indication: Immunosuppression

Tiorfan
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Tranxene
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Dosage: 900 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: 400 ukn, qd
    Indication: Prophylaxis

Zolpidem
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Ganciclovir Sodium; Vidaza; Mycophenolate Mofetil (Cellcept)



Possible Vfend side effects in

Reported by a physician from Poland on 2012-08-21

Patient:

Reactions: Dizziness, Altered State of Consciousness

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 51 year old female

Reported by a consumer/non-health professional from United States on 2012-08-21

Patient: 51 year old female, weighing 47.6 kg (104.8 pounds)

Reactions: Pneumonia, International Normalised Ratio Increased, Blood Disorder, Drug Interaction, Pyrexia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend

Other drugs received by patient possibly interacting with the suspect drug:
Coumadin
    Dosage: 2.5 mg, 1x/day one and half tablet
    Administration route: Oral
    Indication: Anticoagulant Therapy
    Start date: 2012-02-01



Possible Vfend side effects in 82 year old male

Reported by a physician from Japan on 2012-08-10

Patient: 82 year old male, weighing 50.3 kg (110.7 pounds)

Reactions: Photosensitivity Reaction, Squamous Cell Carcinoma

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Administration route: Oral
    Start date: 2011-01-01
    End date: 2011-11-01

Vfend
    Dosage: 200 mg, 3x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2006-08-30
    End date: 2011-11-07

Other drugs received by patient: Trichlormethiazide; Tamsulosin HCL; Ferrous Fumarate; Ludiomil; Clarithromycin; Blostar M; Atarax; Amitriptyline HCL; Amlodipine



Possible Vfend side effects in male

Reported by a health professional (non-physician/pharmacist) from France on 2012-08-10

Patient: male

Reactions: Confusional State, Graft Versus Host Disease, RED Blood Cell Schistocytes Present, Haptoglobin Abnormal, Thrombotic Microangiopathy, Hyperuricaemia, Multi-Organ Failure, Thrombocytopenic Purpura, Thrombocytopenia, Kussmaul Respiration, Haematotoxicity, Haemolysis, Renal Impairment, Renal Failure, Cytomegalovirus Infection, Nervous System Disorder, Human Herpesvirus 6 Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Albumin (Human)
    Dosage: 20 g, qd
    End date: 2012-03-06

Bactrim DS
    Dosage: 1 df, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-04-05

Delursan
    Dosage: 1.5 g, unk
    Administration route: Oral
    Indication: Cholestasis

Effexor
    Dosage: unk
    Administration route: Oral
    Start date: 2012-03-13
    End date: 2012-03-22

Folic Acid
    Dosage: unk
    Indication: Vitamin Supplementation
    End date: 2012-04-05

Heparin Calcium
    Dosage: 7500 (units unknown), once daily
    Indication: Prophylaxis
    End date: 2012-03-21

Levothyroxine Sodium
    Dosage: 150 ug, qd
    Indication: Hypothyroidism

Nicardipine HCL
    Dosage: 50 mg, qd
    Administration route: Oral
    Indication: Hypertension
    End date: 2012-04-15

Omeprazole
    Dosage: unk
    Indication: Prophylaxis

Phenoxymethyl Penicillin
    Dosage: 2 miu, qd
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2012-03-22

Plitican
    Dosage: unk
    Indication: Prophylaxis
    Start date: 2012-03-14
    End date: 2012-03-19

Sandimmune
    Indication: Prophylaxis
    Start date: 2012-01-23
    End date: 2012-04-04

Solu-Medrol
    Dosage: unk
    Indication: Immunosuppression

Tiorfan
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Prophylaxis Against Diarrhoea
    End date: 2012-04-25

Tranxene
    Dosage: unk
    Administration route: Oral
    Indication: Anxiety
    Start date: 2012-03-13
    End date: 2012-03-16

Valganciclovir
    Dosage: 900 mg, qd
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-10
    End date: 2012-03-16

Vfend
    Dosage: 400 unk, qd
    Indication: Prophylaxis

Zolpidem Tartrate
    Dosage: 10 mg, qd
    Administration route: Oral
    Indication: Insomnia
    End date: 2012-03-18

Other drugs received by patient: Ganciclovir Sodium; Cellcept; Vidaza



Possible Vfend side effects in

Reported by a physician from Japan on 2012-08-10

Patient:

Reactions: Haemorrhage Subcutaneous

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 74 year old female

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient: 74 year old female, weighing 53.5 kg (117.7 pounds)

Reactions: Renal Failure, Organ Failure, Full Blood Count Decreased

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Morphine



Possible Vfend side effects in 64 year old female

Reported by a consumer/non-health professional from United States on 2012-08-08

Patient: 64 year old female

Reactions: Impaired Driving Ability, Anxiety, Renal Failure, Sleep Disorder, Dental Caries, Vision Blurred, Depression, Blindness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 70 year old male

Reported by a pharmacist from Japan on 2012-08-07

Patient: 70 year old male

Reactions: Delirium

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 71 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-07

Patient: 71 year old female, weighing 50.3 kg (110.7 pounds)

Reactions: Weight Increased, Blood Alkaline Phosphatase Abnormal, Oedema Peripheral, Alanine Aminotransferase Abnormal, Abdominal Pain Upper, Aspartate Aminotransferase Abnormal

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Potassium; Lasix



Possible Vfend side effects in 66 year old male

Reported by a physician from Italy on 2012-08-06

Patient: 66 year old male

Reactions: Confusional State, Hallucinations, Mixed, Disorientation

Drug(s) suspected as cause:
Vfend

Other drugs received by patient: Lansoprazole; Allopurinol; Calcium Carbonate; Ferrous Sulfate TAB; Bisoprolol Fumarate



Possible Vfend side effects in 74 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient: 74 year old female, weighing 44.0 kg (96.8 pounds)

Reactions: Visual Impairment, Pain, Hallucination, RIB Fracture

Drug(s) suspected as cause:
Tramadol HCL
    Dosage: 25 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2012-07-03

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Aspergillosis
    Start date: 2011-12-01

Vfend
    Indication: Pulmonary Fibrosis

Other drugs received by patient: Mycophenolate Mofetil; Aspirin; Magnesium; Benadryl; Vitamin D; Acyclovir; Tacrolimus; Prednisone; Pantoprazole; Azithromycin; Sulfamethoxazole; Levothyroxine; Lovastatin; Amoxicillin; Multi-Vitamins



Possible Vfend side effects in

Reported by a physician from Japan on 2012-08-02

Patient:

Reactions: Haemorrhage Subcutaneous

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in female

Reported by a physician from France on 2012-08-02

Patient: female, weighing 75.0 kg (165.0 pounds)

Reactions: Hepatitis Acute, Lobar Pneumonia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Atovaquone
    Dosage: 1.5 gram
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-15
    End date: 2012-07-17

Revlimid
    Administration route: Oral
    Start date: 2012-04-13

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Start date: 2012-07-06
    End date: 2012-07-17

Vfend
    Dosage: 400 milligram
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2012-03-06
    End date: 2012-07-17

Other drugs received by patient: RED Blood Cells; Dexamethasone



Possible Vfend side effects in 68 year old female

Reported by a pharmacist from Japan on 2012-07-31

Patient: 68 year old female

Reactions: Hallucination, Auditory, Hallucination, Visual

Drug(s) suspected as cause:
Vfend
    Dosage: 100 mg, 2x/day
    Administration route: Oral

Zithromax
    Dosage: 500 mg, 1x/day
    Administration route: Oral
    Indication: Pneumonia
    Start date: 2012-06-15
    End date: 2012-06-17



Possible Vfend side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-25

Patient: 72 year old male

Reactions: Breast Pain, Hot Flush, Hypogonadism, Gynaecomastia

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Mabthera
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2011-04-15

Methylprednisolone
    Dosage: unk
    End date: 2011-04-15

Oxaliplatin
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Plitican
    Dosage: unk
    End date: 2010-12-10

Polaramine
    Dosage: unk
    Administration route: Oral
    End date: 2011-04-15

Singulair
    Dosage: unk

Vfend
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Lung Disorder
    Start date: 2011-11-01

Zofran
    Dosage: unk
    Administration route: Oral
    End date: 2010-12-10



Possible Vfend side effects in male

Reported by a physician from United States on 2012-07-24

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 36 year old male

Reported by a physician from France on 2012-07-23

Patient: 36 year old male

Reactions: Overdose, Hypotension, Central Nervous System Lesion, Subdural Effusion, Coma, Dermatitis Exfoliative, Rash Maculo-Papular

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Meropenem
    Start date: 2012-02-15
    End date: 2012-02-24

Vancomycin
    Start date: 2012-02-12
    End date: 2012-02-20

Vfend
    Indication: Aspergillosis
    Start date: 2012-02-13
    End date: 2012-02-24

Other drugs received by patient: Fasturtec; Hydrea; Candidas; Tazobactam



Possible Vfend side effects in 72 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient: 72 year old male

Reactions: Hot Flush, Hypogonadism, Gynaecomastia

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Mabthera
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2011-04-15

Methylprednisolone
    Dosage: unk
    End date: 2011-04-15

Oxaliplatin
    Dosage: unk
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Plitican
    Dosage: unk
    End date: 2010-12-10

Polaramine
    Dosage: unk
    Administration route: Oral
    End date: 2011-04-15

Singulair
    Dosage: unk

Vfend
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Lung Disorder
    Start date: 2011-11-01

Zofran
    Dosage: unk
    Administration route: Oral
    End date: 2010-12-10



Possible Vfend side effects in

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-20

Patient:

Reactions: Hot Flush, Hypogonadism, Gynaecomastia

Drug(s) suspected as cause:
Cytarabine
    Dosage: unk
    Indication: Lymphoma
    End date: 2010-12-10

Mabthera
    Dosage: unk
    Indication: Lymphoma
    End date: 2011-04-15

Methylprednisolone
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Oxaliplatin
    Dosage: unk
    Indication: Lymphoma
    End date: 2010-12-10

Plitican
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10

Polaramine
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Singulair
    Dosage: unk
    Indication: Product Used FOR Unknown Indication

Vfend
    Dosage: 50 mg, bid
    Administration route: Oral
    Indication: Lung Disorder
    Start date: 2011-11-01

Zofran
    Dosage: unk
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10



Possible Vfend side effects in male

Reported by a physician from France on 2012-07-19

Patient: male

Reactions: Breast Pain, Hot Flush, Hypogonadism, Gynaecomastia

Drug(s) suspected as cause:
Cytarabine
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Mabthera
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2011-04-15

Methylprednisolone
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Oxaliplatin
    Indication: Mantle Cell Lymphoma Recurrent
    End date: 2010-12-10

Plitican
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10

Polaramine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Singulair
    Indication: Product Used FOR Unknown Indication

Vfend
    Dosage: 50mg twice per day
    Administration route: Oral
    Indication: Lung Disorder
    Start date: 2011-11-01

Zofran
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10



Possible Vfend side effects in 72 year old male

Reported by a physician from France on 2012-07-19

Patient: 72 year old male

Reactions: Hot Flush, Hypogonadism, Gynaecomastia

Drug(s) suspected as cause:
Cytarabine
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10

Mabthera
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-01-01
    End date: 2011-04-15

Methylprednisolone
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Oxaliplatin
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10

Plitican
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10

Polaramine
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2011-04-15

Singulair
    Indication: Product Used FOR Unknown Indication

Vfend
    Administration route: Oral
    Indication: Lung Disorder

Zofran
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    End date: 2010-12-10



Possible Vfend side effects in 55 year old male

Reported by a pharmacist from Japan on 2012-07-12

Patient: 55 year old male

Reactions: Malaise, Exophthalmos, Photophobia, Headache, Decreased Appetite

Drug(s) suspected as cause:
Vfend
    Dosage: 800 mg, unk
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-01
    End date: 2012-05-01

Vfend
    Dosage: 400 mg, unk
    Administration route: Oral
    Start date: 2012-05-01
    End date: 2012-05-01



Possible Vfend side effects in female

Reported by a consumer/non-health professional from United States on 2012-07-12

Patient: female

Reactions: Impaired Driving Ability, Anxiety, Renal Failure, Sleep Disorder, Dental Caries, Vision Blurred, Depression, Blindness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in male

Reported by a physician from United States on 2012-07-11

Patient: male

Reactions: Death

Adverse event resulted in: death

Drug(s) suspected as cause:
Vfend



Possible Vfend side effects in 61 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-10

Patient: 61 year old female, weighing 41.0 kg (90.2 pounds)

Reactions: Deafness Bilateral

Drug(s) suspected as cause:
Vfend
    Dosage: unk
    Administration route: Oral
    End date: 2011-09-06

Vfend
    Dosage: 300 mg, 2x/day
    Administration route: Oral
    Start date: 2011-05-05
    End date: 2011-05-01

Vfend
    Dosage: 250 mg, 2x/day
    Administration route: Oral
    Start date: 2011-05-01
    End date: 2011-07-01

Vfend
    Dosage: 200 mg, 2x/day
    Administration route: Oral
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2010-10-01
    End date: 2011-05-04

Other drugs received by patient: Certican; Certican; Pravastatin Sodium; Pyrazinamide; Bactrim DS; Prograf; Pyrazinamide; Myambutol; Prograf; Certican; Prograf; Valganciclovir; Prograf; Prograf; Valganciclovir; Ansatipin; Rimifon; Prednisone TAB; Zithromax; Irbesartan; Nexium



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014